Literature DB >> 21600174

[Clinical values of triptorelin stimulating test in assessing hypothalamus-pituitary-gonad axis function in male patients with hypothalamus-pituitary-gonad axis disorders].

Xue-yan Wu1, Min Nie, Shuang-yu Lu, Jiang-feng Mao.   

Abstract

OBJECTIVE: To investigate the clinical values of luteinizing hormone-releasing hormone (LHRH) α (triptorelin) stimulating test in the differential diagnoses of hypothalamus-pituitary-gonad axis (HPGA) disorders.
METHODS: A total of 229 male patients with various HPGA disorders were recruited for triptorelin stimulating test. And all patients were followed up for 12 - 48 months until a definite diagnosis was made. The values of triptorelin stimulating test in the differential diagnoses of HPGA disorders were assessed by examining the close relationship between LHmax and the final clinical diagnosis.
RESULTS: (1) LH levels rose steady after an intramuscular injection of triptorelin 100 µg and the time of LHmax appeared at 45 - 60 min. (2) LHmax < 4 U/L indicated the function of HPGA was not activated. LHmax in the range of 4 - 12 U/L indicated the patients might have constitutional delayed puberty development. LHmax > 12 U/L indicated the fulfilled puberty development.
CONCLUSION: Triptorelin stimulating test can precisely evaluate the functions of HPGA in various HPGA disorders and provide valuable information for the differential diagnoses in constitutional delayed puberty development, hypogonadotropic hypogonadism, central and peripheral precocious puberty disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21600174

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  2 in total

1.  Reversal of idiopathic hypogonadotropic hypogonadism: a cohort study in Chinese patients.

Authors:  Jiang-Feng Mao; Hong-Li Xu; Jin Duan; Rong-Rong Chen; Li Li; Bin Li; Min Nie; Le Min; Hong-Bing Zhang; Xue-Yan Wu
Journal:  Asian J Androl       Date:  2015 May-Jun       Impact factor: 3.285

2.  Predictive factors for pituitary response to pulsatile GnRH therapy in patients with congenital hypogonadotropic hypogonadism.

Authors:  Jiang-Feng Mao; Xi Wang; Jun-Jie Zheng; Zhao-Xiang Liu; Hong-Li Xu; Bing-Kun Huang; Min Nie; Xue-Yan Wu
Journal:  Asian J Androl       Date:  2018 Jul-Aug       Impact factor: 3.285

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.